FBRX — Forte Biosciences, Inc.

FBRXForte Biosciences, Inc.

NAS · US · Healthcare · Biotechnology · fortebiorx.com

19.02USD+0.85%Mkt Cap: 392.37M USDP/E: —Last update: 2026-06-01

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate …

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap392.37M USD

Enterprise Value407.77M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-69.38M USD

Revenue/Share—

Last Price19.02 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees22

CountryUS

SectorHealthcare

IndustryBiotechnology

ISINUS34962G1094

Valuation

P/E (Trailing)—

P/E (Forward)-4.60

PEG—

EV/EBITDA-5.30

EV/Revenue—

P/S—

P/B6.30

EPS (TTM)-4.58

EPS (Forward)-4.14

52W Range

7.78040% of range35.80

52W High35.80 USD

52W Low7.780 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-113.75%

ROA-83.81%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-50.88M USD

CapEx (TTM)116.00K USD

FCF Margin—

FCF Yield-7.96%

Net Debt-58.22M USD

Net Debt/EBITDA0.76

Balance Sheet

Debt/Equity—

Current Ratio2.75

Quick Ratio2.49

Book Value/Sh3.026 USD

Cash/Share2.383 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateJun 16, 2020

Splits

Last Split1:25

Split DateAug 28, 2024

Analyst Consensus

Rating1.0 (Strong Buy)

Target (Mean)63.75 USD

Target Range54.00 USD – 75.00 USD

# Analysts4

Ownership

Shares Out.20.48M

Float18.83M

Insiders2.15%

Institutions70.55%

Short Interest

Short Ratio5.4d

Short % Float5.92%

Short % Out.5.89%

Shares Short1.21M

Short (prev mo.)843.65K

Technical

SMA 5026.53 (-28.3%)

SMA 20021.86 (-13.0%)

Beta3.00

S&P 52W Chg27.94%

Avg Vol (30d)208.73K

Avg Vol (10d)194.84K

Technical Indicators

RSI (14)32.3

MACD-1.9694

MACD Signal-1.7587

MACD Hist.-0.2107

BB Upper29.24 USD

BB Middle23.59 USD

BB Lower17.95 USD

BB Width47.83%

ATR (14)2.225 USD

Vol Ratio (20d)1.43x